Model 1 | Model 2 | Model 3 | |
---|---|---|---|
SF, ng/ml | |||
Each 1 mmol/L increase in RC | 82.63 (75.85–89.41) | 65.97 (59.35–72.58) | 73.14 (65.79–80.49) |
Q1 (0.01–0.19) | Reference | Reference | Reference |
Q2 (0.20–0.36) | 18.87 (7.02–30.72) | 15.27 (4.08–26.45) | 15.03 (3.76–26.29) |
Q3 (0.37–0.65) | 51.73 (39.92–63.54) | 39.38 (28.13–50.62) | 38.48 (26.90–50.05) |
Q4 (0.66–8.68) | 113.53 (101.65–125.42) | 86.15 (74.53–97.78) | 86.74 (74.05–99.43) |
P for trend | < 0.001 | < 0.001 | < 0.001 |
TBI, mg/kg | |||
Each 1 mmol/L increase in RC | 1.91 (1.74–2.08) | 1.42 (1.26–1.57) | 1.61 (1.44–1.78) |
Q1 (0.01–0.19) | Reference | Reference | Reference |
Q2 (0.20–0.36) | 0.68 (0.39–0.97) | 0.57 (0.32–0.83) | 0.57 (0.31–0.83) |
Q3 (0.37–0.65) | 1.56 (1.27–1.85) | 1.19 (0.93–1.44) | 1.16 (0.89–1.42) |
Q4 (0.66–8.68) | 2.96 (2.67–3.25) | 2.15 (1.89–2.42) | 2.21 (1.92–2.50) |
P for trend | < 0.001 | < 0.001 | < 0.001 |